Eliseai banks 350m hits 4b valuation accelerated new product development

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 29 Sept, 18:58 UTC

The company surpassed $200 million in ARR in June, doubling revenue year-over-year for five consecutive years, executives said.

businessscience

Sources

• T2Eliseai banks 350m hits 4b valuation accelerated new product developmentFierce Biotech / Fierce Healthcare / MedCity / GEN29 Sept, 18:58